These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 190707)

  • 21. "Anticonvulsant action" of vitamin D in epileptic patients? A controlled pilot study.
    Christiansen C; Rodbro P; Sjö O
    Br Med J; 1974 May; 2(5913):258-9. PubMed ID: 4207965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma concentration of phenytoin in epileptics--importance for the clinician].
    Deonna T; de Crousaz G; Magrini G; Bechtel P; Schelling JL
    Schweiz Med Wochenschr; 1975 Jul; 105(30):936-41. PubMed ID: 1153992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gingival hyperplasia in epileptic patients treated with diphenylhydantoin. Study by light and electron microscopy].
    Tsutsumi V; Hara Ortíz F; Alvarez Fuertes G
    Rev Invest Salud Publica; 1973; 33(3-4):1-16. PubMed ID: 4791088
    [No Abstract]   [Full Text] [Related]  

  • 24. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D.
    Davie MW; Emberson CE; Lawson DE; Roberts GE; Barnes JL; Barnes ND; Heeley AF
    Q J Med; 1983; 52(205):79-91. PubMed ID: 6603629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Altered gamma-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase serum activities in long-term anticonvulsive therapy--comparison of diphenylhydantoin and carbamazepine].
    Aldenhövel HG
    Wien Klin Wochenschr; 1988 Oct; 100(20):680-3. PubMed ID: 2907210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral neuropathy in epileptic patients.
    Swift TR; Gross JA; Ward LC; Crout BO
    Neurology; 1981 Jul; 31(7):826-31. PubMed ID: 6264351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of nerve conduction velocity in patients on diphenylhydantoin therapy.
    Mehrotra TN; Srivastava SS; Goel VK; Sood K; Singh VS; Jain AK
    J Assoc Physicians India; 1992 Sep; 40(9):619-20. PubMed ID: 1339187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phenytoin in the treatment of epilepsy in women].
    Gimeno Calvo B
    Neurologia; 2000; 15(7):320-1. PubMed ID: 11075584
    [No Abstract]   [Full Text] [Related]  

  • 29. Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?
    Johno I; Kuzuya T; Suzuki K; Hasegawa M; Nakamura T; Kitazawa S; Aso K; Watanabe K
    Ther Drug Monit; 1988; 10(1):39-44. PubMed ID: 3376180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loading and conventional dose therapy with phenytoin in children: kinetic profile of parent drug and main metabolite in plasma.
    Wilson JT; Höjer B; Rane A
    Clin Pharmacol Ther; 1976 Jul; 20(1):48-58. PubMed ID: 132330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of diphenylhydantoin (DPH) and tolbutamide in man.
    Wesseling H; Mols-Thürkow I
    Eur J Clin Pharmacol; 1975; 8(1):75-8. PubMed ID: 1233204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downbeat nystagmus with phenytoin.
    Berger JR; Kovacs AG
    J Clin Neuroophthalmol; 1982 Sep; 2(3):209-11. PubMed ID: 6217226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurological signs in diphenylhydantoin intoxication (case reports and review) (author's transl)].
    Wessely P; Mayr N; Binder H; Klingler D
    Wien Klin Wochenschr; 1981 May; 93(10):315-21. PubMed ID: 7257413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of selected parameters of calcium metabolism in epileptics on long-term treatment with diphenylhydantoin].
    Raszeja-Wanic B; Huber Z; Pupek-Musialik D; Saskowski M
    Neurol Neurochir Pol; 1976; 10(4):513-8. PubMed ID: 958581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenytoin-induced dystonia and choreoathetosis in two retarded epileptic children.
    Chalhub EG; Devivo DC; Volpe JJ
    Neurology; 1976 May; 26(5):494-8. PubMed ID: 944401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dental root abnormalities and gingival overgrowth in epileptic patients receiving anticonvulsant therapy.
    Girgis SS; Staple PH; Miller WA; Sedransk N; Thompson T
    J Periodontol; 1980 Aug; 51(8):474-82. PubMed ID: 6931209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral nerve function in long-term therapy with diphenylhydantoin. A clinical and electrophysiologic correlation.
    Eisen AA; Woods JF; Sherwin AL
    Neurology; 1974 May; 24(5):411-7. PubMed ID: 4363815
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of 5,5-diphenylhydantoin on a gingival hyperplasia development.
    Drízhal I; Spacek J; Hrdinová V; Lichý J; Kaut V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1980; 23(5):625-89. PubMed ID: 6972082
    [No Abstract]   [Full Text] [Related]  

  • 39. Diphenylhydantoin-induced cerebellar degeneration.
    Selhorst JB; Kaufman B; Horwitz SJ
    Arch Neurol; 1972 Nov; 27(5):453-5. PubMed ID: 4342796
    [No Abstract]   [Full Text] [Related]  

  • 40. SYNDROME OF GINGIVAL HYPERPLASIA, HIRSUTISM, AND CONVULSIONS; DILANTIN INTOXICATION WITHOUT DILANTIN.
    SNYDER CH
    J Pediatr; 1965 Sep; 67():499-502. PubMed ID: 14339411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.